Mason Carrico
Stock Analyst
(3.32)
# 4,648
Out of 4,648 analysts
54
Total ratings
51.16%
Success rate
2.82%
Average return
Main Sectors:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Reiterates: Overweight | $30 | $16.78 | +78.78% | 5 | Oct 10, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Overweight | $3.5 → $2.5 | $2.51 | -0.40% | 2 | Aug 13, 2024 | |
| NTRA Natera | Reiterates: Overweight | $125 | $123.44 | +1.26% | 4 | Aug 9, 2024 | |
| CSTL Castle Biosciences | Reiterates: Overweight | $37 | $33.64 | +9.99% | 6 | Aug 6, 2024 | |
| HOLX Hologic | Reiterates: Overweight | $92 | $83.72 | +9.89% | 2 | Jul 30, 2024 | |
| NEO NeoGenomics | Reiterates: Overweight | $19 | $14.14 | +34.37% | 1 | Jul 30, 2024 | |
| ILMN Illumina | Reiterates: Overweight | $170 | $153.49 | +10.76% | 5 | Jul 10, 2024 | |
| GH Guardant Health | Reiterates: Overweight | $44 | $23.60 | +86.44% | 4 | May 24, 2024 | |
| CDNA CareDx | Maintains: Overweight | $15 → $18 | $22.93 | -21.50% | 8 | May 13, 2024 | |
| OCX OncoCyte | Reiterates: Equal-Weight | $4 | $2.90 | +37.93% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $5.20 | +73.08% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $9 | $2.62 | +243.51% | 4 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $34.98 | -2.80% | 6 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $24 | $17.83 | +34.60% | 3 | May 4, 2023 |
10x Genomics
Oct 10, 2024
Reiterates: Overweight
Price Target: $30
Current: $16.78
Upside: +78.78%
Pacific Biosciences of California
Aug 13, 2024
Maintains: Overweight
Price Target: $3.5 → $2.5
Current: $2.51
Upside: -0.40%
Natera
Aug 9, 2024
Reiterates: Overweight
Price Target: $125
Current: $123.44
Upside: +1.26%
Castle Biosciences
Aug 6, 2024
Reiterates: Overweight
Price Target: $37
Current: $33.64
Upside: +9.99%
Hologic
Jul 30, 2024
Reiterates: Overweight
Price Target: $92
Current: $83.72
Upside: +9.89%
NeoGenomics
Jul 30, 2024
Reiterates: Overweight
Price Target: $19
Current: $14.14
Upside: +34.37%
Illumina
Jul 10, 2024
Reiterates: Overweight
Price Target: $170
Current: $153.49
Upside: +10.76%
Guardant Health
May 24, 2024
Reiterates: Overweight
Price Target: $44
Current: $23.60
Upside: +86.44%
CareDx
May 13, 2024
Maintains: Overweight
Price Target: $15 → $18
Current: $22.93
Upside: -21.50%
OncoCyte
Apr 17, 2024
Reiterates: Equal-Weight
Price Target: $4
Current: $2.90
Upside: +37.93%
Dec 14, 2023
Initiates: Overweight
Price Target: $9
Current: $5.20
Upside: +73.08%
Nov 13, 2023
Maintains: Overweight
Price Target: $14 → $9
Current: $2.62
Upside: +243.51%
Oct 10, 2023
Reiterates: Overweight
Price Target: $34
Current: $34.98
Upside: -2.80%
May 4, 2023
Reiterates: Equal-Weight
Price Target: $24
Current: $17.83
Upside: +34.60%